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Use of Smokeless Tobacco Among Young Patients 
With Acute Ischemic Stroke
Saba Zaidi
ABSTRACT
To determine the frequency of smokeless tobacco use among young patients with acute ischemic stroke.
METHODS: This cross sectional study was conducted from April to September 2015at emergency department of 
Aga khan university.A total of 135 patients presented with signs and symptoms of acute ischemic stroke were 
included in this research. Participants were selected throughNon probability consecutive samplingtechnique. 
SPSS 20 was used for data analysis.A predesigned proforma was ﬁlled. It has three parts including Socio-
Demographics, Factors for stroke like hypertension, diabetes Mellitus, dyslipidemia, cigarrete smoking and History 
of smokeless tobacco use.Young stroke was deﬁned as patients between 20-49 years of age having symptoms of 
acute ischemic stroke. Smokeless Tobacco users: An individual taking greater than and equal to 3 packets of 
anyone among  gutka, main puri and pan daily for the last two years, is a smokeless tobacco user.
RESULTS: There were 62.2% male and 37.78% were female. Hypertension (81.5%), diabetes mellitus (75.6%) 
and dyslipidemia (63%) were observed that were commonly associated with stroke. Smoking habit was observed 
in 17.04% (23/135) cases. Mean duration of smoking of these patients was 10.22±2.43 years and median number 
of cigarettes smoked per day was5(IQR=2)
Frequency of smokeless chewable tobacco in the form of gutka, mainpuri and pan daily in the ischemic stroke 
patients was found to be 28.15% (38/135) cases.Mean duration of   smokeless chewable tobacco use was 
7.55±2.79 years
CONCLUSION: Frequency of use of chewable tobacco products is high in acute ischemic stroke patients. 
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INTRODUCTION:
Stroke in young has emerged as a major public health 
problem in Pakistan. Several hospital based studies 
have revealed relatively high proportion of young 
stroke. 
Tobacco use is a risk factor for atherosclerosis. 
Stroke-related morbidity stems from the fact that 
tobacco contains over 4000 different chemicals 
including heavy metals and other toxins that promote 
the development of free radicals, inducing vascular 
endothelial dysfunction and inﬂammation, ultimately 
leading to the development and acceleration of the 
atherosclerotic process. Tobacco also causes the 
development of a global circulatory procoagulant 
state thought to be induced by altered hemostatic and 
inﬂammatory marker concentrations. It decreases 
cerebral blood ﬂow, which may further increase the  
riskof clot formation and subsequent stroke risk 
through a slowed ﬂow or stasis phenomenon Oral and 
nasal smokeless tobacco products have been used in 
many countries for centuries. During most of the 20th 
century, use of these products declined in Europe and 
North America, but a reverse trend in prevalence of 
use has been reported in the past few decades, 
particularly among people younger than 40. [9] 
Several studies were done to see association 
between smokeless tobacco use and stroke.Meta-
analysis from both the United States and Sweden 
showed an increased risk of fatal myocardial 
infarction and fatal stroke among users of smokeless 
tobacco products compared with non-users.[10]
Two prospective studies of mortality among the use of 
chewing tobacco[11] done in United States,  provide 
evidence that current use of spit tobacco was 
statistically signiﬁcantly associated with death from 
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coronary heart disease (CHD), stroke, and diseases of 
the respiratory, digestive, and genitourinary  systems, 
but not with death from cancer. Recent study among 
the adolescents and adults of  Karachi squatter 
settlement reported that 40% of the  population was 
using at least one chewable product of betel, areca and 
tobacco on a daily basis.14
The purpose of this study is to determine the frequency 
of smokeless tobacco use in acute ischemic stroke in 
young patients so that strategies can be made for 
further research in this respect and to improve the 
quality of care we provide to these patients.
MATERIALS AND METHODS:
This Cross-sectional study was conducted from April to 
September 2015 in the Aga Khan University Hospital 
Karachi. The sample size was calculated by using the 
WHO sample size calculator, taking the frequency of 
smokeless tobacco in ischemic stroke patient as 22% 
15 and margin of error 7% with the conﬁdence interval 
of 95% than the estimated sample size was 135 
patients with acute ischemic stroke.
Sample was collected through non probability 
consecutive sampling.
Patients age between 20-49 years, bothmale and 
female presented to emergency with signs and 
symptoms of acute ischemic stroke and conﬁrmation 
of ischemia on MRI brain were included. Thosewho will 
have acute stroke due to intra cerebral bleed or 
subarachnoid hemorrhage were excluded. Also 
excluded were those who were not willing to participate 
in the study or transferred out to other hospitals from 
emergency room.
Informed consent from the patient or attendant was 
obtained. Patients were recruited, who fulﬁll the 
inclusion criteria. A predesigned proforma (attached as 
annexure) was ﬁlled out for each patient consenting to 
participate in this study. It has three parts including 
Socio-Demographics, Factors for stroke like 
hypertension, diabetes Mellitus, dyslipidemia, 
cigarrete smoking and History of smokeless tobacco 
use.
The collected information was entered in the SPSS 
version 19 and analyzed through its statistical 
package. Quantitative variable that is age, duration of 
cigarette smoking and smokeless tobacco use was 
presented as mean with standard deviation. 
Qualitative variables were gender, Hypertension, 
Diabetes Mellitus, dyslipidemia and outcome variable 
in ischemic stroke patients that is the presence and 
absence of history of smokeless tobacco use was 
calculated in terms of frequency and percentage.
Stratiﬁcation was  done with regards to age, gender, 
factors predisposing to smokeless tobacco use i:e 
educational status, occupation, factors of stroke like 
hypertension/diabetes/dyslipidemia and comparison 
with the outcome variable i.e. history of smokeless  
tobacco use, to control the effect of modiﬁer by 
applying chi square, taking p value ≤0.05 as 
signiﬁcant.
RESULTS:
A total of 135 patients presented to ER with signs and 
symptoms of acute ischemic stroke were included 
inthis research. There were 62.2% male and 37.78% 
were female.Hypertension (81.5%), diabetes mellitus 
(75.6%) and dyslipidemia (63%) were observed that 
w e r e  c o m m o n l y  a s s o c i a t e d  w i t h  s t r o k e .
Smoking habit was observed in 17.04% (23/135) 
cases. Mean duration of smoking of these patients was 
10.22±2.43 years and median number of cigarettes 
smoked per day was 5(IQR=2) In this study, frequency 
of smokeless chewable tobacco in the form of gutka, 
mainpuri and pan daily in the ischemic stroke patients 
was found to be 28.15% (38/135) cases. Mean 
duration of smokeless chewable tobacco use was 
7.55±2.79 years. Rate of smokeless chewable 
tobacco was high in male cases as compare to female 
cases (35.7% vs. 15.7%)
DISCUSSION:
In Pakistan and South Asian subcontinent, the popular 
chewing products are paan, chaalia, gutka, niswar and 
tumbaku[21]. The composition of these products may 
vary from one to another but the main ingredients 
remain betel, areca and tobacco. Paan contains areca 
nut, betel leaf and calcium hydroxide but tobacco and 
various other spices are also commonly added[22]. 
Industrially prepared mixture of areca nut, lime, 
catechin containing substance, sandalwood fragrance 
with tobacco (gutka) or without tobacco (chaalia) were 
introduced in recent decades, which have contributed 
to growth and use of these products.[23]In Pakistan, a 
recent study among the adolescents and adults of a 
Karachi squatter settlement reported that 40% of the 
population was using at least one chewable product of 
betel, areca and tobacco on daily basis. [20,14] 
Among the established vascular risk factors for stroke, 
hypertension is the single most important modiﬁable 
risk factor for both ischemic and hemorrhagic stroke 
[26]. Kamal et al. noted hypertension in 64% of stroke 
patients in their multiethnic community-based survey 
[27]In our study we foundhypertensionin 81.5% of 
stroke patients.
In our study, frequency of smokeless chewable 
tobacco in the form of gutka, mainpuri and pan daily in 
the young ischemic stroke patients was found to be 
28.15% (38/135).  Mean duration of smokeless 
chewable tobacco use was 7.55±2.79 years. In one 
study of Pakistan, frequency of chewable tobacco in 
the form of pan, gutka or supari (locally available forms 
with areca and betel nut) in the ischemic stroke 
patients was found to be 22%15.
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CONCLUSION:
Frequency of use of chewable products is high in 
ischemic stroke patients. Industrially prepared 
products, chaalia and gutka, are gaining popularity 
among the youth and it can cause a signiﬁcant health 
burden on the community. Strategies can be made for 
further research in this respect and to improve the 
quality of care we provide to these patients.
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